Targeting validated drivers of cancer, Nima Farzan, CEO, Kinnate Biopharma
Synopsis: Nima Farzan is the CEO of Kinnate Biopharma, a clinical-stage precision oncology company focused on expanding on the promise of targeted therapies for those battling cancer. The company is ...
25 Loka 202329min
Advancing bold therapies for neuronal health, Mark Litton, President & CEO, Athira Pharma
Synopsis: Mark Litton, Ph.D., is the President and CEO of Athira Pharma, a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neur...
18 Loka 202329min
Pioneering RNA editing to deliver the future of medicine, Ram Aiyar, President & CEO, Korro Bio
Synopsis: Ram Aiyar, Ph.D., MBA, is the President & CEO of Korro Bio. Korro Bio harnesses the body’s natural RNA editing machinery to make precise, single-base RNA edits to modulate protein function,...
11 Loka 202327min
Unlocking the technological potential of biology, Seemay Chou, Co-Founder & CEO, Arcadia Science
Synopsis: Seemay Chou, Ph.D., is the Co-Founder and CEO of Arcadia Science, a research and development company leveraging the biology of emerging research organisms. Seemay sits down with Alok to dis...
4 Loka 202344min
Pioneering tRNA therapeutics, Michelle Werner, CEO, Alltrna & CEO-Partner, Flagship Pioneering
Synopsis: Michelle Werner is the CEO of Alltrna and a CEO-Partner at Flagship Pioneering. Alltrna is the world’s first tRNA platform company to decipher tRNA biology and pioneer tRNA therapeutics to...
27 Syys 202329min
Breaking new ground in the treatment of fibrosis, Bernard Coulie, President & CEO, Pliant Tx
Synopsis: Bernard Coulie is the President and CEO of Pliant Therapeutics, a clinical stage biopharmaceutical company focused on discovering and developing novel therapeutics that seek to halt progres...
20 Syys 202333min
Transforming medicine through precision epigenomic control, Mahesh Karande, Pres. & CEO, Omega Tx
Synopsis: Mahesh Karande is the President and CEO of Omega Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines for...
13 Syys 202329min
Catalyzing the next generation of mRNA medicines, Joseph Payne, Founder, Pres. & CEO, Arcturus Tx
Synopsis: Joseph Payne is the Founder, President and CEO of Arcturus Therapeutics, a global late-stage clinical messenger RNA medicines and vaccines company focused on the discovery, development and ...
6 Syys 202329min
